EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic and proteomic analyses of SH-SY5Y neuroblastoma cells treated with amisulpride

Tsung-Ming Hu, Hsin-Yao Tsai, Shih-Hsin Hsu, Min-Chih Cheng iD

Acta Neuropsychiatrica · 2025

DOI: 10.1017/neu.2025.10040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropsychiatrica, 2025. Verfasst von Tsung-Ming Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Taipei Veterans General Hospital Yuli Branch, Hualien, Taiwan. Hauptthemen laut MEDLINE: Amisulpride, Neuroblastoma, Antipsychotic Agents, Transcriptome. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Amisulpride, a substituted benzamide derivative, has a unique pharmacological profile characterised by a high affinity for dopaminergic D 2 /D 3 receptors, as well as an affinity for 5-HT 7 receptors. Its effectiveness and safety surpass those of traditional antipsychotic drugs and multi-receptor antipsychotic medications in improving global symptoms, including both positive and negative symptoms. This makes it a compelling subject for study. However, the molecular mechanisms that contribute to its clinical efficacy in treating schizophrenia remain largely unexplored.

Methods

We assessed cell viability following amisulpride treatment using the MTT and a real-time cell viability assay. Subsequently, we conducted RNA-seq and LC-MS/MS analyses to identify differentially expressed genes and proteins in SH-SY5Y neuroblastoma cells treated with amisulpride.

Results

In the present study, we used RNA-seq analysis to identify downregulated expression of a transcriptional factor, FOSB , in amisulpride-treated SH-SY5Y neuroblastoma cells, while using LC-MS/MS analysis to identify multiple differentially expressed proteins in these cells. Among these differentially expressed proteins, we confirmed four proteins (ACTG1, ANP32E, CLTC, IPO8) that are differentially expressed under the administration of amisulpride.

Conclusion

Our data reveal novel insights into the role of amisulpride in modulating the differential expression of genes and proteins. These findings, which involve genes/proteins related to AP-1 transcription factor family gene regulation, cytoskeleton, histone binding activity, the intracellular trafficking of receptors and endocytosis of a variety of macromolecules, and nuclear localisation signal, are particularly significant as they shed light on the molecular underpinnings of the clinical efficacy of amisulpride and the pathogenesis of schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmisulprideNeuroblastomaAntipsychotic AgentsTranscriptomeHumansCell Line, TumorProteomicsCell SurvivalTandem Mass SpectrometrySchizophreniaGene Expression Profiling

Stichwörter der Autor:innen

AmisulprideLC-MS/MSRNA sequencingSH-SY5Yschizophrenia

Substanzen

AmisulprideAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry, Taipei Veterans General Hospital Yuli Branch, Hualien, Taiwan.
  • Department of Management, Fo Guang University, Jiaosi, Yilan, Taiwan.

ORCID-Profile: Min-Chih Cheng

Zitieren

APA

Hu, T. M., Tsai, H. Y., Hsu, S. H., & Cheng, M. C. (2025). Transcriptomic and proteomic analyses of SH-SY5Y neuroblastoma cells treated with amisulpride. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2025.10040

Vancouver

Hu TM, Tsai HY, Hsu SH, Cheng MC. Transcriptomic and proteomic analyses of SH-SY5Y neuroblastoma cells treated with amisulpride. Acta Neuropsychiatrica. 2025. doi:10.1017/neu.2025.10040

BibTeX
@article{Hu2025,
  author = {Hu, Tsung-Ming and Tsai, Hsin-Yao and Hsu, Shih-Hsin and Cheng, Min-Chih},
  title = {Transcriptomic and proteomic analyses of SH-SY5Y neuroblastoma cells treated with amisulpride},
  journal = {Acta Neuropsychiatrica},
  year = {2025},
  doi = {10.1017/neu.2025.10040}
}
Kostenlos starten →